Herpes Simplex Clinical Trials

8 recruitingLast updated: May 13, 2026

There are 8 actively recruiting herpes simplex clinical trials across 6 countries. Studies span Phase 2, Phase 1, Phase 3, Phase 4. Top locations include Beerzel, Belgium, Beuzet, Belgium, Bielefeld, Germany. Updated daily from ClinicalTrials.gov.


Herpes Simplex Trials at a Glance

8 actively recruiting trials for herpes simplex are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Beerzel, Beuzet, and Bielefeld. Lead sponsors running herpes simplex studies include Jena University Hospital, Kaiser Permanente, and AProf Dr Karin Ried.

Browse herpes simplex trials by phase

Treatments under study

About Herpes Simplex Clinical Trials

Looking for clinical trials for Herpes Simplex? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Herpes Simplex trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Herpes Simplex clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 1Phase 2

Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.

Herpes Simplex KeratitisCorneal Neovascularization
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT07329686
Recruiting
Phase 3

Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL

Hospital-Acquired PneumoniaCommunity-acquired PneumoniaVentilator associated pneumonia+2 more
Jena University Hospital616 enrolled28 locationsNCT06134492
Recruiting

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

SarcoidosisBirdshot ChorioretinitisBehcet Disease+5 more
Oregon Health and Science University125 enrolled1 locationNCT07065747
Recruiting

Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients

OncologyTransplantation InfectionHerpesviridae Infections+2 more
University of Pisa200 enrolled1 locationNCT05198570
Recruiting
Phase 2

A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis

Herpes Simplex Virus Type I Stromal Keratitis
Shanghai BDgene Co., Ltd.40 enrolled1 locationNCT06474442
Recruiting
Phase 4

Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections.

Herpes Simplex
Labo'Life140 enrolled6 locationsNCT04065971
Recruiting

Treating Genital Herpes Infection to Reduce Racial Disparities in the Risk of Severe Maternal Morbidity

Racial DisparitiesGenital Herpes SimplexMaternal Morbidity
Kaiser Permanente339,000 enrolled1 locationNCT05429346
Recruiting

Electro-Magnetic-Frequency Therapy (EMF) for Chronic Fatigue

Viral Reactivation with Cyto-Megalo-Virus (CMV)Viral Reactivation with Herpes Simplex Virus (HSV)Viral Reactivation with Epstein-Barr Virus (EBV)+1 more
AProf Dr Karin Ried100 enrolled1 locationACTRN12624000178549